Colgate-Palmolive Company $CL Shares Sold by Legacy Wealth Asset Management LLC

09 Oct 2026, 07:52 by Doug Wharley · The Cerbat Gem

Legacy Wealth Asset Management LLC reduced its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 27.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 17,811 shares of the company’s stock after selling 6,780 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in Colgate-Palmolive were worth $1,520,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Corient Private Wealth LP boosted its position in shares of Colgate-Palmolive by 29.0% in the second quarter. Corient Private Wealth LP now owns 639,604 shares of the company’s stock valued at $58,639,000 after acquiring an additional 143,812 shares during the period. Brandywine Financial Group increased its position in Colgate-Palmolive by 35,612.3% during the first quarter. Brandywine Financial Group now owns 72,853 shares of the company’s stock worth $6,209,000 after acquiring an additional 72,649 shares during the period. Bank of America Corp DE acquired a new position in Colgate-Palmolive during the 2nd quarter valued at $567,483,000. SEB Asset Management AB acquired a new position in Colgate-Palmolive during the 1st quarter valued at $91,149,000. Finally, Robinhood Asset Management LLC bought a new stake in Colgate-Palmolive in the 2nd quarter valued at $11,554,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $88.07 on Friday. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The stock has a market capitalization of $70.21 billion, a P/E ratio of 34.95, a P/E/G ratio of 4.07 and a beta of 0.33. The business has a 50-day moving average price of $89.16 and a two-hundred day moving average price of $88.77.

Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $5.36 billion. During the same quarter in the previous year, the company earned $0.92 EPS. Colgate-Palmolive’s revenue was up 4.9% on a year-over-year basis. Equities analysts predict that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.4%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 84.13%.

Wall Street Analysts Forecast Growth

CL has been the topic of several research reports. Citigroup boosted their price objective on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. TD Cowen boosted their price target on Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a research note on Monday, August 3rd. Barclays upped their price target on Colgate-Palmolive from $80.00 to $87.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating on the stock in a report on Monday. Finally, UBS Group boosted their price objective on Colgate-Palmolive from $106.00 to $109.00 and gave the company a “buy” rating in a research report on Monday, August 3rd. Twelve investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $98.65.

Read Our Latest Report on Colgate-Palmolive

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 161,021 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the transaction, the chief executive officer owned 362,231 shares of the company’s stock, valued at $33,296,273.52. This represents a 30.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction on Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the transaction, the chief operating officer owned 64,901 shares of the company’s stock, valued at $5,974,137.05. The trade was a 13.35% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 175,191 shares of company stock valued at $16,110,903. 0.43% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.